Marshall Wace’s Jin Medical International ZJYL Stock Holding History

Marshall Wace’s Portfolio ZJYL Stock Details ZJYL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-9,554	Closed	-$734K	–	3041
2024 Q1	$734K	Buy	+9,554	New	+$1.4M	﹤0.01%	1778

Other funds holding ZJYL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Winton Group London, United Kingdom $2.85B AUM 30.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SOW

State of Wyoming Cheyenne, Wyoming $844M AUM 37.96% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Marshall Wace's ZJYL Position: Q2 2024 in Review

Marshall Wace sold out of Jin Medical International (ZJYL) in Q2 2024, closing a stake of 9,554 shares — an estimated $734K sold.

Marshall Wace first reported a position in ZJYL in Q1 2024 and held it in 1 quarter. The position peaked at $734K in Q1 2024. 12 funds tracked by Wall St. Rank hold ZJYL as of Q2 2024.

Marshall Wace reported no remaining Jin Medical International position as of Q2 2024 after selling out during the quarter.
Marshall Wace sold 9,554 Jin Medical International shares in Q2 2024, an estimated $734K.
Marshall Wace first reported a position in Jin Medical International in Q1 2024 and held it in 1 quarter.
Marshall Wace's Jin Medical International position peaked at $734K in Q1 2024.
12 funds tracked by Wall St. Rank held Jin Medical International as of Q2 2024.

Based on Marshall Wace's 13F filing for Q2 2024, filed 14 Aug 2024.